Automatic Estimation of the Apnea-hypopnea Index Using Neural Networks to Detect Sleep Apnea
Automatic Estimation of Apnea-hypopnea Index (AHI) Using Neural Networks to Assist in the Diagnosis of Sleep Apnea-hypopnea Syndrome (SAHS)
1 other identifier
observational
322
1 country
1
Brief Summary
The sleep apnea hypopnea syndrome (SAHS) is a respiratory disorder characterized by frequent breathing cessations (apneas) or partial collapses (hypopneas) during sleep. These respiratory events lead to deep oxygen desaturations, blood pressure and heart rate acute changes, increased sympathetic activity and cortical arousals. The gold standard method for SAHS diagnosis is in-hospital, technician-attended overnight polysomnography (PSG). However, this methodology is labor-intensive, expensive and time-consuming, which has led to large waiting lists, delaying diagnosis and treatment. Blood oxygen saturation (SpO2) from nocturnal pulse oximetry (NPO) provides relevant information to detect apneas, it can be easily recorded ambulatory and it is less expensive and highly reliable. The investigators hypothesize that an automatic analysis of single oximetric recordings at home could provide essential information on the diagnosis of SAHS. The aim of this study is two-fold: firstly, the research focuses on assessing the reliability and usefulness of NPO carried out at patient's home in the context of SAHS detection and, secondly, the study aims at assessing the performance of an automatic regression model of the AHI by means of neural networks using information from NPO recordings. To achieve this goal, both PSG and NPO studies are carried out. A polysomnography equipment (E-Series, Compumedics) is used for standard in-hospital PSG studies, whereas a portable pulseoximeter (WristOX2 3150, Nonin) is used for ambulatory NPO. NPO is carried out the day immediately before or after the PSG at patient's home. Patients are assigned to carry out the NPO study before or after the in-hospital PSG randomly. In addition, in-hospital attended oximetry is also performed simultaneously to the PSG using the portable pulseoximeter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 15, 2014
CompletedFirst Posted
Study publicly available on registry
May 21, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedMay 21, 2014
May 1, 2014
8 months
May 15, 2014
May 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Correlation between our estimated AHI from oximetry and real AHI from gold standard PSG
A measure of correlation between our estimation of the AHI and the real AHI derived from conventional in-hospital PSG will be measured by means of the intra-class correlation coefficient (ICC). This measure shows how similar are both indexes (estimated AHI and real AHI) in order to assess the severity of SAHS using our estimated AHI. In addition, Bland and Altman plots of agreement between NPO-based estimated AHI and PSG-based standard AHI will be drawn in order to assess under/over-estimation along the whole range of AHI values.
12 months after the inclusion of the last patient
Percentage of patients correctly classified
Percentage of patients correctly classified by the optimum portable NPO-based algorithm using the NPO-based estimated AHI. PSG is used as the reference gold standard method. Subjects with an AHI \>= 10 event per hour (e/h) are considered as suffering from SAHS.
12 months after the inclusion of the last patient
Secondary Outcomes (10)
Prevalence of SAHS
12 months (inclusion period)
Severity of SAHS
12 months (inclusion period)
Demographic and anthropometric characteristics
12 months (inclusion period)
Clinical characteristics of the study population
12 months (inclusion period)
Patients' lifestyle
12 months (inclusion period)
- +5 more secondary outcomes
Study Arms (2)
SAHS negative
Subjects derived to the sleep unit due to suspicion of suffering from sleep apnea which finally do not have the disease according to standard PSG
SAHS positive
Subjects derived to the sleep unit due to suspicion of suffering from sleep apnea which finally have the disease according to standard PSG
Eligibility Criteria
Subjects derived to the reference sleep unit from primary care with suspicion of suffering from SAHS due to daytime hypersomnolence, loud snoring, nocturnal choking and awakenings, and/or apnoeic events
You may qualify if:
- Men and women over 18 years old
- Subjects submitted to the sleep unit due to previous symptoms of sleep apnea (daytime hypersomnolence, loud snoring, nocturnal choking and awakenings, and/or apnoeic events)
- Written informed consent signed
You may not qualify if:
- Subjects under 18 years old
- Subjects not signing the informed consent
- Presence of any previously diagnosed sleep disorders: narcolepsy, insomnia, chronic sleep deprivation, regular use of hypnotic or sedative medications and restless leg syndrome
- Patients with chronic diseases: congestive heart failure, renal failure, neuromuscular diseases, chronic respiratory failure
- Patients with \> 50% of central apneas or the presence of Cheyne-Stokes respiration
- Previous CPAP treatment for SAHS diagnosis
- A medical history that may interfere with the study objectives or, in the opinion of the investigator, compromise the conclusions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Río Hortega
Valladolid, Valladolid, 47012, Spain
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Felix Del Campo, PhD, MD
Hospital Universitario Río Hortega, University of Valladolid
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, MD
Study Record Dates
First Submitted
May 15, 2014
First Posted
May 21, 2014
Study Start
July 1, 2013
Primary Completion
March 1, 2014
Study Completion
July 1, 2014
Last Updated
May 21, 2014
Record last verified: 2014-05